首頁 > 市場調查報告書 > 製藥

以基因為基之藥物開發

市場調查報告書

商品編碼

1547294

全球基因組個人化健康市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Genomics Personalized Health Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 170 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球基因組個人化健康市場需求預計將從 2023 年的 567.8 億美元增至 2032 年的近 874.1 億美元，2024-2032 年研究期間複合年成長率為 4.91%。

基因組個人化健康是一種獨特的醫療保健方法，其中根據遺傳資訊修改患者的醫療治療。隨著對人類基因組的更好理解以及醫生在患者的醫療和外科管理中使用這些資訊的方式的發展，一個更複雜的系統已經發展起來。這些可以幫助診斷各種複雜的疾病，並導致基於基因分析的更客製化的治療方法的開發，消除一些可能在特定患者群體中失敗或產生不良副作用的傳統藥物。該研究重點是基因組發現、分析和翻譯方法的設計、開發和使用，以促進基因組學驅動的醫療保健並改善臨床和個人化健康結果。個人化醫療是一個新領域，它利用個人的基因譜來幫助指導有關疾病預防、診斷和治療的決策。醫生可以利用患者的基因譜來幫助他們選擇合適的藥物或療法，並以正確的劑量或方案進行給藥。

市場動態

全球基因組學個人化健康市場是由生物標記相關研發活動支出不斷增加所推動的。隨著癌症和糖尿病等慢性疾病變得更加普遍，對基於基因組學的個人化健康的需求預計將會增加。製藥業的擴張以及治療反應的評估和預測預計將推動該行業向前發展。此外，個人化基因組學健康市場受到蓬勃發展的分子生物學領域和醫療保健領域技術進步的影響。同樣，老年人口的成長增加了多種慢性病的盛行率，促進了市場的成長。診斷醫療保健和政府增加的投資預計將成為基因組學個人化健康市場成長的關鍵驅動力。然而，新興國家缺乏意識、耗時的監管規則、資料安全和監管問題以及重大資料管理問題阻礙了市場擴張。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球基因組個人化健康市場的每個細分市場進行了包容性評估。基因組學個人化健康產業的成長和趨勢為這項研究提供了整體方法。

市場區隔

基因組學個人化健康市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人群以及即將到來的機會。

依技術

NGS平台
逆轉錄聚合酶連鎖反應
微陣列
基因分析儀

通過測試

腫瘤學測試
傳染病檢測
自體免疫疾病檢測
其他

按最終用戶

學術界及研究機構
診斷中心
其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲基因組個人化健康市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。基因組個人化健康市場的主要參與者包括 Illumine、QIAGEN、Thermo Fisher Scientific、Bio-Rad Laboratories、Roche、Lonza Group。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：基因組個人化健康公司的競爭格局

基因組學個人化健康市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

頂級公司市佔率分析
市場集中度
Illumine

公司概況
公司收入
產品
最新動態

QIAGEN

公司概況
公司收入
產品
最新動態

Thermo Fisher Scientific

公司概況
公司收入
產品
最新動態

Bio-Rad Laboratories

公司概況
公司收入
產品
最新動態

Roche

公司概況
公司收入
產品
最新動態

Lonza Group

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資料和最新進展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11216670

The global demand for Genomics Personalized Health Market is presumed to reach the market size of nearly USD 87.41 Billion by 2032 from USD 56.78 Billion in 2023 with a CAGR of 4.91% under the study period 2024-2032.

Genomic personalized health is a unique approach to healthcare in which a patient's medical treatment is modified based on genetic information. A more sophisticated system has evolved from a better understanding of the human genome and ways for physicians to use that information in their patients' medical and surgical management. These can aid in diagnosing a wide range of complex disorders and lead to the development of more customized treatments based on genetic profiling, removing some conventional medications that may fail or have adverse side effects in a specific patient population. The research focuses on the design, development, and use of genomic discovery, analysis, and translation methodologies to promote genomics-driven healthcare and improve clinical and personalized health outcomes. Personalized medicine is a new field that uses a person's genetic profile to help guide decisions about illness prevention, diagnosis, and treatment. Doctors can use a patient's genetic profile to assist them in choosing the proper medication or therapy for them and administer it at the correct dose or regimen.

MARKET DYNAMICS

The global genomics personalized health market is driven by rising spending on research and development activities tied to biomarkers. Demand for genomics-based personalized health is expected to increase as chronic diseases like cancer and diabetes become more prevalent. The pharmaceutical sector's expansion and the assessment and prediction of treatment response are projected to propel the industry forward. Furthermore, the personalized genomics health market is affected by the booming molecular biology sector and technological advancements in the healthcare sector. Again, the growing elderly population has increased the prevalence of several chronic diseases, boosting the market's growth. Increased investment by diagnostic health care and governments is expected to be a critical driver of the genomics personalized health market's growth. However, the market expansion is hampered by a lack of awareness in emerging nations, time-consuming regulatory rules, data security and regulatory concerns, and significant data management issues.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Genomics Personalized Health. The growth and trends of Genomics Personalized Health industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Genomics Personalized Health market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Technology

NGS Platforms
RT-PCR
Microarray
Genetic Analyzers

By Test

Oncology Testing
Infectious Disease Testing
Autoimmune Disease Testing
Others

By End-User

Academics & Research Institutes
Diagnostic Centers
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Genomics Personalized Health market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Genomics Personalized Health market include Illumine, QIAGEN, Thermo Fisher Scientific, Bio-Rad Laboratories, Roche, Lonza Group. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. GENOMICS PERSONALIZED HEALTH - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Technology
- 3.7.2 Market Attractiveness Analysis By Test
- 3.7.3 Market Attractiveness Analysis By End-User
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL GENOMICS PERSONALIZED HEALTH MARKET ANALYSIS BY TECHNOLOGY

5.1. Overview By Technology
5.2. Historical and Forecast Data Analysis By Technology
5.3. NGS Platforms Historic and Forecast Sales By Regions
5.4. RT-PCR Historic and Forecast Sales By Regions
5.5. Microarray Historic and Forecast Sales By Regions
5.6. Genetic Analyzers Historic and Forecast Sales By Regions

6. GLOBAL GENOMICS PERSONALIZED HEALTH MARKET ANALYSIS BY TEST

6.1. Overview By Test
6.2. Historical and Forecast Data Analysis By Test
6.3. Oncology Testing Historic and Forecast Sales By Regions
6.4. Infectious Disease Testing Historic and Forecast Sales By Regions
6.5. Autoimmune Disease Testing Historic and Forecast Sales By Regions
6.6. Others Historic and Forecast Sales By Regions

7. GLOBAL GENOMICS PERSONALIZED HEALTH MARKET ANALYSIS BY END-USER

7.1. Overview By End-User
7.2. Historical and Forecast Data Analysis By End-User
7.3. Academics & Research Institutes Historic and Forecast Sales By Regions
7.4. Diagnostic Centers Historic and Forecast Sales By Regions
7.5. Others Historic and Forecast Sales By Regions

8. GLOBAL GENOMICS PERSONALIZED HEALTH MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE GENOMICS PERSONALIZED HEALTH COMPANIES

9.1. Genomics Personalized Health Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF GENOMICS PERSONALIZED HEALTH INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Illumine
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. QIAGEN
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Thermo Fisher Scientific
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Bio-Rad Laboratories
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Roche
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Lonza Group
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments